Is Aerosolized Pentamidine for Pneumocystis Pneumonia Prophylaxis in Renal Transplant Recipients Not as Safe as We Might Think?

Antimicrobial Agents and Chemotherapy
N MacesicM L Grayson

Abstract

Outbreaks ofPneumocystispneumonia have been described in renal transplant recipients. Aerosolized pentamidine is frequently used for prophylaxis in this setting. We report our experience with aerosolized pentamidine use in 56 renal transplant recipients. We found high rates of adverse reactions in patients with chronic respiratory disease.

References

Sep 14, 2000·Proceedings of the National Academy of Sciences of the United States of America·C M DrysdaleS B Liggett
Apr 5, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mark G J de BoerJan P Vandenbroucke
Feb 28, 2009·The Journal of Infection·C WardA M L Lever
Jan 5, 2011·American Journal of Respiratory and Critical Care Medicine·Andrew H LimperUNKNOWN American Thoracic Society Fungal Working Group
Feb 18, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Solène Le GalGilles Nevez
Mar 21, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Monica SassiJoseph A Kovacs
Feb 9, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marta Bodro, David L Paterson
Jun 7, 2013·Kidney International·Jeremy R ChapmanPeter S MacDonald

❮ Previous
Next ❯

Citations

Jun 7, 2018·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Mark G J de BoerShunsuke Mori
Sep 13, 2017·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·K F UrbancicJ A Trubiano
Apr 12, 2020·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Benjamin HanischMonica I Ardura
Feb 20, 2020·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Kelsey S BrownMelissa D Makii
Jul 23, 2021·Reviews in Endocrine & Metabolic Disorders·John G RizkKamyar Kalantar-Zadeh

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Related Papers

Anales de medicina interna : organo oficial de la Sociedad Española de Medicina Interna
R Vicente UllF Alcacer García
JAMA : the Journal of the American Medical Association
B Merz
© 2021 Meta ULC. All rights reserved